03-10-2023Last month, HIV.gov had the opportunity to speak with our colleagues from NIH, CDC, and HRSA and with community members about the...

03-08-2023Watch and share HIV.gov s final interview from the 2023 Conference on Retroviruses and Opportunistic Infections (CROI) with Dr. D zon Dixon Diallo, Founder a...

03-02-2023During the 2023 Conference on Retroviruses and Opportunistic Infections (CROI), HIV.gov spoke with LaRon Nelson, PhD, RN, FNP, FNAP, FAAN, of Yale University ab…

02-24-2023As the 2023 Conference on Retroviruses and Opportunistic Infections (CROI) wound to a close this week, HIV.gov spoke with CDC s Dr. Jono Mermin and Dr. John B..…

02-23-2023HIV.gov visited with Dr. Laura Cheever during the 2023 Conference on Retroviruses and Opportunistic Infections (CROI) this week. D...

02-22-2023As the latest research on HIV and other infectious diseases continued to be presented at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI)…

02-22-2023The ongoing search for an HIV vaccine was among the topics discussed during the 2023 Conference on Retroviruses and Opportunistic Infections (CROI). HIV.gov spo…

02-21-2023Cross-posted from NIH Newsroom NIH-supported study demonstrates injectable ART may improve outcomes in underserved patients A lo...

02-21-2023During the first full day of research presentations at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI), HI...

02-16-2023Next week, HIV.gov will be sharing updates on the latest HIV research from the 2023 Conference on Retroviruses and Opportunistic...

02-09-2023HIV.gov will be sharing live updates on the latest HIV research being presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI), whic…

02-15-2022Cross-posted from NIAID Newsroom Woman Has Remained Without Detectable HIV for 14 MonthsA woman with HIV who received a cord blood...

02-09-2022Next week, for the 11th year in a row, HIV.gov will begin sharing updates on the latest HIV research from the 2022 virtual Confer...

03-11-2021As the 2021 virtual Conference on Retroviruses and Opportunistic Infections (CROI) concluded, NIH’s Dr. Carl Dieffenbach joined HIV.gov for a conversation…

03-09-2021In an HIV.gov video conversation yesterday, NIH’s Dr. Carl Dieffenbach shared highlights from HIV research presented at the 2021 virtual Conference on Ret…

03-09-2021Cross-posted from NCHHSTP Newsroom CDC scientists will present nearly 30 abstracts at the 2021 Conference on Retroviruses and Op...

03-04-2021Next week, HIV.gov will be sharing updates on the latest HIV research from the 2021 virtual Conference on Retroviruses and Opport...

04-23-2020As a participant in the recent virtual 2020 Conference on Retroviruses and Opportunistic Infections (CROI), I found several studi...

03-31-2020The 2020 Conference on Retroviruses and Opportunistic Infections (CROI) was convened as a virtual conference earlier this month....

03-11-2020Cross-posted from NIAID Newsroom Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study o...